Tomohiko Ichikawa Selected Research

Matrix Metalloproteinases (MMPs)

4/2008	[Bony lesion with prostate cancer].
11/2005	The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter.
9/2003	Increased in situ gelatinolytic activity in renal cell tumor tissues correlates with tumor size, grade and vessel invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomohiko Ichikawa Research Topics

Disease

112	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 01/2002
93	Neoplasms (Cancer) 04/2024 - 02/2002
30	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 03/2002
28	Neoplasm Metastasis (Metastasis) 12/2022 - 06/2002
13	Urinary Bladder Neoplasms (Bladder Cancer) 11/2023 - 01/2016
10	Carcinoma (Carcinomatosis) 01/2024 - 04/2009
8	Hyperaldosteronism (Conn Syndrome) 01/2020 - 03/2012
7	Carcinogenesis 03/2024 - 09/2003
6	Disease Progression 01/2018 - 12/2006
5	Cushing Syndrome 11/2023 - 02/2004
5	Hypertension (High Blood Pressure) 04/2023 - 01/2010
5	Adenoma (Adenomas) 01/2023 - 03/2012
5	Pain (Aches) 02/2014 - 07/2003
5	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2012 - 11/2005
3	Diabetes Mellitus 04/2023 - 04/2017
2	Leiomyosarcoma 12/2023 - 10/2022
2	Obesity 04/2023 - 04/2010
2	Hyperlipidemias (Hyperlipidemia) 04/2023 - 01/2010
2	Erectile Dysfunction 04/2023 - 12/2006
2	Urologic Neoplasms (Urological Cancer) 10/2022 - 01/2022
2	Urinary Calculi (Urinary Calculus) 01/2021 - 09/2005
2	Testicular Germ Cell Tumor 01/2021 - 10/2020
2	Hernia (Hernias) 03/2020 - 01/2009
2	Infections 01/2019 - 12/2008
2	Interstitial Cystitis (Interstitial Cystitis, Chronic) 05/2018 - 01/2017
2	Pheochromocytoma 03/2016 - 02/2005
2	Azoospermia 01/2016 - 06/2002
2	Shock 06/2013 - 06/2008

Drug/Important Bio-Agent (IBA)

35	MicroRNAs (MicroRNA)IBA 12/2020 - 04/2011
34	AndrogensIBA 01/2023 - 07/2003
27	Hormones (Hormone)IBA 02/2024 - 09/2002
14	Androgen Receptors (Androgen Receptor)IBA 02/2024 - 05/2002
13	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 07/2003
12	Testosterone (Sustanon)FDA Link 02/2024 - 03/2005
10	Proteins (Proteins, Gene)FDA Link 06/2021 - 11/2005
9	Biomarkers (Surrogate Marker)IBA 02/2024 - 02/2005
9	RNA (Ribonucleic Acid)IBA 06/2021 - 01/2017
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2002
7	Androgen Antagonists (Antiandrogens)IBA 09/2018 - 02/2004
6	Amino Acid Transport Systems (Amino Acid Transporter)IBA 04/2024 - 01/2020
5	2- amino- 3- (4- ((5- amino- 2- phenylbenzo(d)oxazol- 7- yl)methoxy)- 3,5- dichlorophenyl)propanoic acidIBA 04/2024 - 01/2020
5	AldosteroneIBA 01/2023 - 03/2012
5	Docetaxel (Taxotere)FDA Link 06/2022 - 02/2014
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 07/2003
4	Essential Amino AcidsIBA 04/2024 - 09/2021
4	Tyrosine Kinase InhibitorsIBA 05/2023 - 01/2017
4	Alkaline PhosphataseIBA 12/2022 - 06/2010
4	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2012
4	LigandsIBA 12/2014 - 11/2005
3	Leucine (L-Leucine)FDA Link 04/2024 - 01/2002
3	pembrolizumabIBA 05/2023 - 11/2021
3	C-Reactive ProteinIBA 12/2022 - 07/2006
3	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2021 - 02/2004
3	LipidsIBA 06/2021 - 12/2015
3	Sunitinib (Sutent)FDA Link 01/2021 - 10/2014
3	Tumor Biomarkers (Tumor Markers)IBA 01/2018 - 07/2006
3	bicalutamide (Casodex)FDA LinkGeneric 05/2016 - 02/2004
3	Antihypertensive Agents (Antihypertensives)IBA 10/2014 - 03/2012
3	Zoledronic Acid (Zometa)FDA Link 11/2012 - 04/2008
3	naftopidilIBA 09/2012 - 08/2008
3	Diphosphonates (Bisphosphonates)IBA 09/2010 - 07/2006
3	Matrix Metalloproteinases (MMPs)IBA 04/2008 - 09/2003
2	TOR Serine-Threonine KinasesIBA 04/2024 - 03/2023
2	Histones (Histone)IBA 03/2024 - 01/2021
2	Large Neutral Amino Acid-Transporter 1IBA 01/2024 - 11/2019
2	cabazitaxel FDA Link 01/2024 - 03/2022
2	AcidsIBA 08/2023 - 02/2010
2	Amino Acids FDA Link 03/2023 - 05/2016
2	Hemoglobins (Hemoglobin)IBA 12/2022 - 02/2014
2	CarbonIBA 10/2022 - 05/2006
2	Coloring Agents (Dyes)IBA 01/2022 - 05/2008
2	Cisplatin (Platino)FDA LinkGeneric 11/2021 - 01/2016
2	Gemcitabine FDA Link 11/2021 - 04/2009
2	Messenger RNA (mRNA)IBA 09/2020 - 02/2004
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020 - 02/2014
2	Indicators and Reagents (Reagents)IBA 11/2019 - 07/2006
2	enzalutamideIBA 04/2019 - 05/2016
2	SteroidsIBA 01/2018 - 02/2004
2	CollagenIBA 05/2016 - 09/2003
2	EnzymesIBA 05/2016 - 07/2004
2	Vasopressins (Vasopressin)IBA 10/2015 - 02/2004
2	Collagen Type I (Type I Collagen)IBA 11/2012 - 06/2010
2	Analgesics (Analgesic Drugs)IBA 01/2010 - 11/2009
2	Insulin-Like Growth Factor I (IGF-1)IBA 02/2009 - 05/2006
2	Flutamide (Eulexin)FDA LinkGeneric 09/2008 - 02/2004

Therapy/Procedure

59	Therapeutics 03/2024 - 02/2002
32	Castration 04/2024 - 02/2004
17	Adrenalectomy 11/2023 - 02/2004
14	Prostatectomy (Retropubic Prostatectomy) 12/2023 - 03/2005
10	Drug Therapy (Chemotherapy) 12/2023 - 11/2006
10	Nephrectomy 12/2023 - 12/2006
10	Heavy Ion Radiotherapy 01/2023 - 08/2012
6	Radiotherapy 07/2019 - 05/2006
4	Nephroureterectomy 12/2019 - 11/2017
3	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 11/2017
3	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 06/2013 - 09/2005
3	Immunotherapy 01/2011 - 10/2009
3	Lasers (Laser) 05/2009 - 02/2005
2	Transurethral Resection of Bladder 10/2022 - 11/2020
2	Aftercare (After-Treatment) 09/2012 - 05/2007